Conference Coverage
Conference Coverage
Later-line tisotumab vedotin shows survival benefit in metastatic cervical CA
Results are similar to cemiplimab, but unlike TV, cemiplimab is not yet approved for the indication.
Conference Coverage
PD-1 inhibitor improves outcomes in NHL subtype
With toripalimab and radiotherapy, progression-free survival at 2 years is high for extranodal NK/T-cell lymphoma in those who respond poorly to...
Latest News
Ready to start engaging on social media? A dermatologist shares tips
Think about your goal. Is it to raise awareness of various dermatologic conditions or to grow your business?
Conference Coverage
Neoadjuvant, adjuvant, or both? The debate in NSCLC rages on
The question of whether to give upfront immunochemotherapy in resectable non–small cell lung cancer, wait until after surgery, or give both...
Conference Coverage
Rare lymphomas: Desperately seeking new txs
Experts seek global collaboration to develop novel therapies for peripheral T-cell lymphomas, a rare form of non-Hodgkin lymphoma with many...
Conference Coverage
‘We finally made it’: Amivantamab comes of age in NSCLC
Data from three trials with amivantamab in advanced EGFR-mutant NSCLC have yielded “exciting” results with experts hailing the drug as standard of...
Latest News
Induction chemotherapy in first line improves survival for locally advanced cervical cancer
With similar results reported for pembrolizumab, a question has arisen about how to incorporate induction chemotherapy and pembrolizumab into a...
Conference Coverage
Ocular MALT lymphoma: Radiation reduces relapse
Mortality rates from early-stage ocular MALT lymphoma are low, with relapse rates lowered by radiation therapy.
Conference Coverage
Frontline myeloma treatments: ASCT vs. CAR T
Experts debate whether CAR T-cell therapy could eventually replace autologous stem cell transplant (ASCT) as the standard of care for multiple...
Conference Coverage
Dato-DXd trumps chemo in advanced HR+/HER2– breast cancer
The antibody-drug conjugate datopotamab deruxtecan had better efficacy and safety than chemotherapy for patients with endocrine-resistant...
Conference Coverage
‘Why did I choose this?’ Tackling burnout in oncology
Building a sustainable oncology workforce will not be easy, but improving staffing shortages and integrating resilience training can help, experts...